证券之星消息，11月24日种植业板块较上一交易日下跌0.46%，神农种业领跌。当日上证指数报收于 3836.77，上涨0.05%。深证成指报收于12585.08，上涨0.37%。种植业板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603336 宏辉果蔬 | | = 490.36万 | 3.40% | -213.87万 | -1.48% | -276.49万 | -1.92% | | 002215 | 诺普信 | 312.70万 | 2.01% | -979.34万 | -6.29% | 666.64万 | 4.28% | | 600359 新农开发 | | 127.51万 | 1.37% | -763.64万 | -8.20% | 636.12万 | 6.83% | | ...

11月21日，华绿生物跌4.84%，成交额6828.70万元。两融数据显示，当日华绿生物获融资买入额589.58 万元，融资偿还598.55万元，融资净买入-8.97万元。截至11月21日，华绿生物融资融券余额合计 4625.30万元。 融资方面，华绿生物当日融资买入589.58万元。当前融资余额4625.30万元，占流通市值的2.25%，融资 余额低于近一年50%分位水平，处于较低位。 融券方面，华绿生物11月21日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00 元；融券余量0.00股，融券余额0.00元，超过近一年90%分位水平，处于高位。 资料显示，江苏华绿生物科技集团股份有限公司位于江苏省泗阳县绿都大道88号，成立日期2010年6月8 日，上市日期2021年4月12日，公司主营业务涉及食用菌的研发、工厂化种植及销售。主营业务收入构 成为：金针菇70.73%，真姬菇29.27%。 截至9月30日，华绿生物股东户数1.03万，较上期减少9.42%；人均流通股9132股，较上期增加11.88%。 2025年1月-9月，华绿生物实现营业收入8.68亿元，同比增长17.98%；归母净 ...

Core Insights - The agriculture sector experienced a decline of 0.54% on November 19, with Hainan Rubber leading the losses [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Sector Performance - Notable gainers in the agriculture sector included: - Beidahuang (600598) with a closing price of 15.06, up 1.35%, trading volume of 373,000 shares, and a turnover of 560 million yuan [1] - Nuofushin (002215) closed at 11.55, up 1.05%, with a trading volume of 198,400 shares and a turnover of 230 million yuan [1] - Major decliners included: - Hainan Rubber (601118) closed at 5.90, down 3.28%, with a trading volume of 697,800 shares and a turnover of 413 million yuan [2] - Shennong Agriculture (300189) closed at 5.62, down 2.77%, with a trading volume of 2,051,200 shares and a turnover of 1.149 billion yuan [2] Capital Flow - The agriculture sector saw a net outflow of 202 million yuan from institutional investors, while retail investors contributed a net inflow of 228 million yuan [2] - Specific stock capital flows included: - Beidahuang (600598) had a net inflow of 27.18 million yuan from institutional investors, while retail investors contributed a net inflow of 9.57 million yuan [3] - Hainan Rubber (601118) experienced a net outflow of 4.92 million yuan from institutional investors [3]

Core Points - Hualu Bio announced the election of Mr. Xia Weiwei as the employee representative director of the company's fifth board of directors [2] Company Summary - The announcement was made on the evening of November 14 [2] - The election reflects the company's governance structure and employee representation [2] Industry Summary - The move may indicate a trend towards increased employee involvement in corporate governance within the biotechnology sector [2] - Such governance changes could impact investor perception and engagement in the industry [2]

上海市锦天城律师事务所 关于 江苏华绿生物科技集团股份有限公司 2025 年第一次临时股东会 的 致：江苏华绿生物科技集团股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受江苏华绿生物科技集团 股份有限公司（以下简称"公司"）委托，就公司召开 2025 年第一次临时股东 会的有关事宜，根据《中华人民共和国公司法》（以下简称《公司法》）、《上 市公司股东会规则》等有关法律、法规、规章和其他规范性文件以及《江苏华绿 生物科技集团股份有限公司章程》（以下简称《公司章程》）的有关规定，出具 本法律意见书。 上海市锦天城律师事务所 地址：上海市浦东新区银城中路 501 号上海中心大厦 9、11、12 楼 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于江苏华绿生物科技集团股份有限公司 2025 年第一次临时 股东会的法律意见书 法律意见书 为出具本法律意见书，本所律师对本次股东会所涉及的相关事项进行了必要 的核查和验证，审查了本所律师认为出具该法律意见书所需审查的相关文件、资 料的电子版和副本，并得到公司如下保 ...

证券代码：300970 证券简称：华绿生物 公告编号：2025-045 江苏华绿生物科技集团股份有限公司 关于非独立董事辞职暨选举职工代表董事的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、非独立董事辞职情况 江苏华绿生物科技集团股份有限公司（以下简称"公司"）董事会于近日收 到非独立董事夏伟伟先生的书面辞职报告。因公司组织架构调整，夏伟伟先生提 请辞去公司第五届董事会非独立董事职务，辞去董事职务后，夏伟伟先生将继续 担任公司采购总监职务。 根据《中华人民共和国公司法》（以下简称"公司法"）及《公司章程》等 有关规定，夏伟伟先生的辞职不会导致公司董事会人数低于法定最低人数，不会 影响公司董事会的正常运行，亦不会对公司的日常经营管理及未来发展产生不利 影响，夏伟伟先生的辞职报告自送达董事会之日起生效。夏伟伟先生担任公司董 事的原定任期为 2023 年 6 月 19 日至第五届董事会任期届满之日，即 2023 年 6 月 20 日至 2026 年 6 月 19 日止。 截至本公告披露日，夏伟伟先生直接持有公司股份 92,000 股，通过宿迁华 鑫投资 ...

2、本次股东会不涉及变更以往股东会已通过的决议； 3、为保护中小投资者利益，提高中小投资者对公司股东会决议的重大事项 的参与度，公司对中小投资者的表决情况单独计票，中小投资者指单独或者合计 持有本公司5%以上股份的股东以外的其他股东，且不包括持有公司股份的董事 及高级管理人员。 一、会议召开情况 （一）会议召开时间： 证券代码：300970 证券简称：华绿生物 公告编号：2025-046 江苏华绿生物科技集团股份有限公司 2025 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 特别提示 1、本次股东会不存在增加或者否决议案的情形； 1、会议召开时间：2025 年 11 月 14 日（星期五）14:30 2、网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间 为：2025 年 11 月 14 日上午 9:15 至 9:25，9:30 至 11:30，下午 13:00 至 15:00； 通过深圳证券交易所互联网投票系统进行网络投票的具体时间为：2025 年 11 月 14 日上午 9:15 至下午 15:00 内的任意时 ...

Market Overview - The planting industry sector declined by 0.39% on November 12, with Shennong Seed Industry leading the drop [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance - Notable gainers included Honglian Huan Shu with a closing price of 10.53, up 1.15%, and Yasheng Group at 3.27, up 0.93% [1] - Shennong Seed Industry closed at 5.19, down 1.52%, with a trading volume of 903,400 shares and a transaction value of 473 million [2] - The overall trading volume and transaction values for various stocks in the planting sector were significant, with several stocks experiencing minor fluctuations in their closing prices [1][2] Capital Flow - The planting industry sector saw a net outflow of 160 million from main funds, while retail investors contributed a net inflow of 141 million [2] - The detailed capital flow indicated that major funds were predominantly withdrawing from stocks like Xin Nong Kai Fa and Guo Tou Feng Le, while retail investors were more active in stocks like San Shi Yu Zhi [3]

Core Viewpoint - The company, Hualu Bio, reassured investors about its commitment to accurate and complete information disclosure, emphasizing that its production and operations are normal, and management remains confident in the company's development [2] Group 1 - The company responded to investor inquiries on November 4, indicating that its information disclosure is truthful, accurate, and complete [2] - The company acknowledged that various factors influence its stock price in the secondary market and urged investors to maintain a correct perspective [2] - Management expressed strong confidence in the company's future growth and development [2]

Core Insights - The company, Hualu Bio (300970), reported a significant increase in industry scale and product variety since its listing, leading to a noticeable decline in the revenue proportion from enoki mushrooms [1] Group 1 - The company confirmed that its revenue from enoki mushrooms has decreased significantly as the scale and variety of its products have expanded post-listing [1] - The company emphasized the authenticity, accuracy, and completeness of its information disclosure, urging investors to rely on the disclosed information [1]